CLINICAL_TRIALS
trial_result
· 2014-06-11
Clinical Trial Update: Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A [Phase 3]
Summary
Phase 3 trial assessing safety and efficacy of turoctocog alfa in previously treated male children with Haemophilia A completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2014-06-11